Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor

Lung Cancer

Volumn 31, Issue 2-3, 2001, Pages 193-202

  Toyoshima, Eri ^a   Ohsaki, Yoshinobu ^a   Nishigaki, Yutaka ^a   Fujimoto, Yoshinori ^a   Kohgo, Yutaka ^a   Kikuchi, Kenjiro ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Epidermal growth factor receptor; Heparan sulfate proteoglycan; Lung cancer; Syndecan 1; Transforming growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; PARAFFIN; PEPTIDE DERIVATIVE; POLYCLONAL ANTIBODY; PR 39; PROTEIN ANTIBODY; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SYNDECAN; SYNDECAN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

AGED; ANTIBODIES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; PROTEOGLYCANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL ANALYSIS; SYNDECAN-1; SYNDECANS; TUMOR CELLS, CULTURED;

EID: 0035144787     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00184-7     Document Type: Article

References (29)

1. Proteoglycans as modulators of growth factor activities
2. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF
3. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential
4. Heparan sulfate proteoglycan expression in human lung-cancer cells
5. The role of syndecan-1 in malignancies
6. Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder
7. v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
8. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer
9. Overexpression of epidermal growth factor and insulin-like growth factor-I receptors and autocrine stimulation in human esophageal carcinoma cells
10. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient
11. Expression of epidermal growth factor receptors in human lung tumors
12. Expression of epidermal growth factor receptors in four histologic cell types of lung cancer
13. Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer
14. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines
15. Amino acid sequence of PR-39: isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides
16. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich anti-microbial peptide from wounds
17. 1, and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts: enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypican
18. Syndecan-1 and -4 are induced during wound repare of neonatal but not fetal skin
19. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma
20. Prognostic significance of transforming growth factor-α in human esophageal carcinoma
21. Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma
22. Isolation of RNA using guanidinium salts
23. Heparan sulphate proteoglycan expression in human primary liver tumors
24. Cell surface syndecan-1 on distinct cell types differs in fine structure and ligand binding of its heparan sulfate chains
25. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine
26. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscope study
27. Basic science of small cell lung cancer
28. Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior
29. Biology of lung cancer